136 related articles for article (PubMed ID: 20634329)
21. The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin.
Deville JG; Goldfarb J; Kaplan SL; Equils O; Huang DB; Ang JY; Salazar JC
J Antimicrob Chemother; 2010 Oct; 65(10):2267-70. PubMed ID: 20705627
[No Abstract] [Full Text] [Related]
22. Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
Jenkins I
J Hosp Med; 2007 Sep; 2(5):343-4. PubMed ID: 17935250
[No Abstract] [Full Text] [Related]
23. Successful treatment of vancomycin-resistant enterococcal ventriculitis in a pediatric patient with linezolid.
Maranich AM; Rajnik M
Mil Med; 2008 Sep; 173(9):927-9. PubMed ID: 18816936
[TBL] [Abstract][Full Text] [Related]
24. Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA): successful treatment with linezolid in combination with intraventricular vancomycin.
Amod F; Moodley I; Peer AK; Sunderland J; Lovering A; Wootton M; Nadvi S; Vawda F
J Infect; 2005 Apr; 50(3):252-7. PubMed ID: 15780422
[TBL] [Abstract][Full Text] [Related]
25. First confirmed case of vancomycin-resistant Enterococcus faecium meningitis in Turkey: case report and literature review.
Inan D; Gunseren F; Colak D; Saba R; Kazan S; Mamikoglu L
J Chemother; 2004 Dec; 16(6):608-11. PubMed ID: 15700856
[TBL] [Abstract][Full Text] [Related]
26. Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature.
Tan TY; Pitman I; Penrose-Stevens A; Simpson BA; Flanagan PG
J Infect; 2000 Jul; 41(1):95-7. PubMed ID: 11041712
[TBL] [Abstract][Full Text] [Related]
27. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
Till M; Wixson RL; Pertel PE
Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
[TBL] [Abstract][Full Text] [Related]
28. [Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium].
Berberian G; Castro G; Fistolera S; Travaglianti M; Lopardo H; Mastroianni A; Rosanova MT
Rev Argent Microbiol; 2009; 41(1):34-8. PubMed ID: 19391524
[TBL] [Abstract][Full Text] [Related]
29. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
[TBL] [Abstract][Full Text] [Related]
30. Long-term treatment with linezolid in a patient with osteomyelitis undergoing hemodialysis.
Berenguer N; Ferrández O; Barbosa F; Urbina O; Espona M; Grau S
J Chemother; 2012 Aug; 24(4):226-8. PubMed ID: 23040688
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
[TBL] [Abstract][Full Text] [Related]
32. Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment.
Bonora MG; Ligozzi M; Luzzani A; Solbiati M; Stepan E; Fontana R
Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):197-8. PubMed ID: 16498524
[No Abstract] [Full Text] [Related]
33. Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.
Yim J; Smith JR; Rybak MJ
Pharmacotherapy; 2017 May; 37(5):579-592. PubMed ID: 28273381
[TBL] [Abstract][Full Text] [Related]
34. Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children.
Tamma PD; Hsu AJ
Curr Opin Infect Dis; 2014 Dec; 27(6):517-27. PubMed ID: 25313503
[TBL] [Abstract][Full Text] [Related]
35. Vancomycin-resistant Enterococcus faecium osteomyelitis: successful treatment with quinupristin-dalfopristin.
Summers M; Misenhimer GR; Antony SJ
South Med J; 2001 Mar; 94(3):353-5. PubMed ID: 11284529
[TBL] [Abstract][Full Text] [Related]
36. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.
Gonzales RD; Schreckenberger PC; Graham MB; Kelkar S; DenBesten K; Quinn JP
Lancet; 2001 Apr; 357(9263):1179. PubMed ID: 11323048
[TBL] [Abstract][Full Text] [Related]
37. [Linezolid-resistant Enterococcus faecium: the first G2576T mutation in Turkey].
Afşar I; Barış I; Sener AG; Köksal V; Demirci M
Mikrobiyol Bul; 2012 Jul; 46(3):516-8. PubMed ID: 22951666
[TBL] [Abstract][Full Text] [Related]
38. Linezolid treatment of glycopeptide-resistant Enterococcus faecium in very low birth weight premature neonates.
Hoehn R; Groll AH; Schaefer V; Bauer K; Schloesser RL
Int J Antimicrob Agents; 2006 Mar; 27(3):256-8. PubMed ID: 16480855
[TBL] [Abstract][Full Text] [Related]
39. [Enterococcus faecium cholangitis resistant to vancomycin and quinupristin-dalfopristin].
Maseda E; Uña R; Ureta P; Royo C
Med Clin (Barc); 2002 Sep; 119(7):276-7. PubMed ID: 12236991
[No Abstract] [Full Text] [Related]
40. Antimicrobial therapy and local toxicity of intraventricular administration of vancomycin in a neonate with ventriculitis.
Nava-Ocampo AA; Mojica-Madera JA; Villanueva-García D; Caltenco-Serrano R
Ther Drug Monit; 2006 Jun; 28(3):474-6. PubMed ID: 16778737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
